Atlas Trials

Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Clinical trial NCT06963697 · AVAILABLE

Trial details

NCT number
NCT06963697
Sponsor
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.